386900007: anticorps monoclonal contre le virus respiratoire syncytial (substance)

SNOMED CT Concept\substance\...

\Substance categorized by disposition\agent antiviral\Respiratory syncytial virus monoclonal antibody
\Substance categorized by disposition\Immunomodulator\Immunosuppressant (substance)\Respiratory syncytial virus monoclonal antibody

\Drug or medicament (substance)\Anti-infective agent (substance)\agent antiviral\Respiratory syncytial virus monoclonal antibody
\Drug or medicament (substance)\Immunosuppressant (substance)\Respiratory syncytial virus monoclonal antibody
\Drug or medicament (substance)\Monoclonal antibody (substance)\Respiratory syncytial virus monoclonal antibody

\substance catégorisée selon sa structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody (substance)\Respiratory syncytial virus monoclonal antibody

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody (substance)\Respiratory syncytial virus monoclonal antibody

\Biological substance\Immunologic substance\Antibody\Monoclonal antibody (substance)\Respiratory syncytial virus monoclonal antibody
\Biological substance\Polypeptide\Protein\Antibody\Monoclonal antibody (substance)\Respiratory syncytial virus monoclonal antibody

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1461078016 Palivizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1481014019 Palivizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

62701000087115 Respiratory syncytial virus monoclonal antibody en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)

76391000087119 anticorps monoclonal contre le virus respiratoire syncytial fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)

76401000087116 anticorps monoclonal contre le virus respiratoire syncytial (substance) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)

830751000172117 palivizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Respiratory syncytial virus monoclonal antibody	est un(e) (attribut)	Immunosuppressant (substance)	true	Inferred relationship	Some
Respiratory syncytial virus monoclonal antibody	est un(e) (attribut)	Monoclonal antibody (substance)	true	Inferred relationship	Some
Respiratory syncytial virus monoclonal antibody	est un(e) (attribut)	anticorps monoclonal chimérique souris-humain d'isotype IgG	false	Inferred relationship	Some
Respiratory syncytial virus monoclonal antibody	est un(e) (attribut)	agent antiviral	true	Inferred relationship	Some
Respiratory syncytial virus monoclonal antibody	Has disposition (attribute)	Murine-human monoclonal immunoglobulin G antibody (disposition)	false	Inferred relationship	Some
Respiratory syncytial virus monoclonal antibody	Has disposition (attribute)	Immunomodulator (disposition)	true	Inferred relationship	Some
Respiratory syncytial virus monoclonal antibody	Has disposition (attribute)	Antiviral (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Palivizumab-containing product in parenteral dose form	a pour principe actif (attribut)	True	Respiratory syncytial virus monoclonal antibody	Inferred relationship	Some	1
Palivizumab only product	a pour principe actif (attribut)	True	Respiratory syncytial virus monoclonal antibody	Inferred relationship	Some	1
Palivizumab only product in parenteral dose form	a pour principe actif (attribut)	True	Respiratory syncytial virus monoclonal antibody	Inferred relationship	Some	1
SYNAGIS 100 milligrams per milliliter powder for solution for injection Boehringer Ingelheim (BI) Pharma KG (real clinical drug)	a pour principe actif (attribut)	False	Respiratory syncytial virus monoclonal antibody	Inferred relationship	Some	1
SYNAGIS 100 milligrams per milliliter powder for solution for injection Boehringer Ingelheim (BI) Pharma KG (real clinical drug)	Has precise active ingredient	True	Respiratory syncytial virus monoclonal antibody	Inferred relationship	Some	1
SYNAGIS 100 milligrams per milliliter powder for solution for injection Boehringer Ingelheim (BI) Pharma KG (real clinical drug)	Has basis of strength substance (attribute)	True	Respiratory syncytial virus monoclonal antibody	Inferred relationship	Some	1
Product containing precisely palivizumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has precise active ingredient	True	Respiratory syncytial virus monoclonal antibody	Inferred relationship	Some	1
Product containing precisely palivizumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has basis of strength substance (attribute)	True	Respiratory syncytial virus monoclonal antibody	Inferred relationship	Some	1
médicament contenant palivizumab (produit médicinal)	a pour principe actif (attribut)	True	Respiratory syncytial virus monoclonal antibody	Inferred relationship	Some	1
Palivizumab 50mg powder and solvent for injection solution vial (product)	a pour principe actif (attribut)	False	Respiratory syncytial virus monoclonal antibody	Inferred relationship	Some
Palivizumab 100mg injection (product)	a pour principe actif (attribut)	False	Respiratory syncytial virus monoclonal antibody	Inferred relationship	Some
Palivizumab 100mg powder for injection 1mL vial (product)	a pour principe actif (attribut)	False	Respiratory syncytial virus monoclonal antibody	Inferred relationship	Some
Palivizumab 100mg powder and solvent for injection solution vial (product)	a pour principe actif (attribut)	False	Respiratory syncytial virus monoclonal antibody	Inferred relationship	Some
Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has precise active ingredient	True	Respiratory syncytial virus monoclonal antibody	Inferred relationship	Some	1
Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has basis of strength substance (attribute)	True	Respiratory syncytial virus monoclonal antibody	Inferred relationship	Some	1
Palivizumab 50 mg powder for solution for injection vial	Has precise active ingredient	True	Respiratory syncytial virus monoclonal antibody	Inferred relationship	Some	1
Palivizumab 50 mg powder for solution for injection vial	Has basis of strength substance (attribute)	True	Respiratory syncytial virus monoclonal antibody	Inferred relationship	Some	1

Reference Sets

Immunoglobulin codes for vaccines reference set (foundation metadata concept)